Statistical issues in drug development
By Stephen Senn
"Statistical issues in drug development" was published by John Wiley & Sons in 2007 - Chichester, England, it has 498 pages and the language of the book is English.
“Statistical issues in drug development” Metadata:
- Title: ➤ Statistical issues in drug development
- Author: Stephen Senn
- Language: English
- Number of Pages: 498
- Publisher: John Wiley & Sons
- Publish Date: 2007
- Publish Location: Chichester, England
“Statistical issues in drug development” Subjects and Themes:
- Subjects: ➤ Statistical methods - Drug development - Statistics as Topic - Methods - Clinical Trials as Topic - Drug Design - Developpement - Geneesmiddelen - MEDICAL - Pharmacy - Statistics - Research and Development - Medicaments - Drug Guides - Nursing - Pharmacology - Clinical Trials - Statistiek - Methodes statistiques - Médicaments - Développement - Méthodes statistiques - Drugs, research - Pharmaceutical arithmetic - Drug Industry - Drug Evaluation
Edition Specifications:
- Pagination: xix, 498 p. :
Edition Identifiers:
- The Open Library ID: OL21577129M - OL1687241W
- Library of Congress Control Number (LCCN): 2007045553
- ISBN-13: 9780470018774
- ISBN-10: 0470018771
- All ISBNs: 0470018771 - 9780470018774
AI-generated Review of “Statistical issues in drug development”:
"Statistical issues in drug development" Table Of Contents:
- 1- A brief and superficial history of statistics for drug developers
- 2- Design and interpretation of clinical trials as seen by a statistician
- 3- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals
- 4- The work of the pharmaceutical statistician
- 5- Allocating treatments to patients in clinical trials
- 6- Baselines and covariate information
- 7- The measurement of treatment effects
- 8- Demographic subgroups : representation and analysis
- 9- Multiplicity
- 10- Intention to treat, missing data and related matters
- 11- One-sided and two-sided tests and other issues to do with significance and P-values
- 12- Determining the sample size
- 13- Multicentre trials
- 14- Active control equivalence studies
- 15- Meta-analysis
- 16- Cross-over trials
- 17- n-of-1 trials
- 18- Sequential trials
- 19- Dose-finding
- 20- Concerning pharmacokinetics and pharmacodynamics
- 21- Bioequivalence studies
- 22- Safety data, harms, drug monitoring, and pharmaco-epidemiology
- 23- Pharmaco-economics and portfolio management
- 24- Concerning pharmacogenetics, pharmacogenomics, and related matters.
Read “Statistical issues in drug development”:
Read “Statistical issues in drug development” by choosing from the options below.
Search for “Statistical issues in drug development” downloads:
Visit our Downloads Search page to see if downloads are available.
Find “Statistical issues in drug development” in Libraries Near You:
Read or borrow “Statistical issues in drug development” from your local library.
- The WorldCat Libraries Catalog: Find a copy of “Statistical issues in drug development” at a library near you.
Buy “Statistical issues in drug development” online:
Shop for “Statistical issues in drug development” on popular online marketplaces.